Maimon Carole Ben - Sep 16, 2022 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
President and CEO, Director
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Stock symbol
LRMR
Transactions as of
Sep 16, 2022
Transactions value $
$100,000
Form type
4
Date filed
9/19/2022, 07:00 AM
Previous filing
May 12, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRMR Common Stock Purchase $100K +31.7K +126.56% $3.15 56.8K Sep 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.